Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics | 969 | 2022 | |||||||||
Atea Pharmaceuticals | 292 | 2023q3 | |||||||||
Athira Pharma | 97 | 2023q3 | |||||||||
AtriCure | 1,185 | 2022 | |||||||||
Aurinia Pharmaceuticals | 958 | 2021 | |||||||||
Aurora Cannabis | 1,021 | 2022q2 | |||||||||
Autolus Therapeutics | 1,099 | 2023q3 | |||||||||
Avanos Medical | 864 | 2023 | |||||||||
Avantor | 15,280 | 2023q3 | |||||||||
AxoGen | 622 | 2023q3 | |||||||||
Axsome Therapeutics | 3,872 | 2024q2 | |||||||||
Aytu BioPharma | 10 | 2022 | |||||||||
Bausch Health | 3,175 | 2023 | |||||||||
Baxter International | 21,298 | 2023 | |||||||||
Bayer | 28,862 | 2022 | |||||||||
Beam Therapeutics, Inc. | 1,970 | 2024q2 | |||||||||
Becton, Dickinson and Co | 70,015 | 2024q1 | |||||||||
Bellerophon Therapeutics | 0 | 2021 | |||||||||
Beyond Air | 50 | 2024q1 | |||||||||
BeyondSpring | 39 | 2023q2 |